Moxibustion Protects Dopaminergic Neurons in Parkinson's Disease through Antiferroptosis

Zifeng Huang1,2, Wenwen Si1, Xinrong Li1,2

  • 1Traditional Chinese Medicine Innovation Research Center, Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, Guangdong 518104, China.

Insights

Moxibustion treatment effectively reduces ferroptosis, a key factor in Parkinson's disease (PD) neurodegeneration. This therapy improves motor symptoms and dopaminergic neuron survival in PD rats, offering a potential alternative treatment.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Traditional Chinese Medicine

Background:

  • Ferroptosis, a form of regulated cell death, is increasingly linked to dopaminergic neuron loss in Parkinson's disease (PD).
  • The precise mechanisms controlling ferroptosis in PD pathogenesis and effective therapeutic interventions remain areas of active investigation.
  • Moxibustion, a traditional Chinese medicine technique, is clinically observed to ameliorate PD motor symptoms, suggesting a potential role in modulating disease processes.

Purpose of the Study:

  • To investigate the efficacy of moxibustion in modulating ferroptosis and its impact on dopaminergic neuron survival in a rat model of Parkinson's disease.
  • To evaluate the effects of moxibustion on key ferroptosis markers, including glutathione peroxidase 4 (GPX4), Ferritin Heavy Chain 1 (FTH1), reactive oxygen species (ROS) levels, and mitochondrial morphology.

Main Methods:

  • A Parkinson's disease rat model was established using stereotactic injection of 6-hydroxydopamine.
  • PD rats were treated with moxibustion using Shi's moxa sticks.
  • Ferroptosis levels were assessed by measuring GPX4 and FTH1 expression, ROS generation, and mitochondrial ultrastructure.

Main Results:

  • Moxibustion treatment significantly reduced behavioral scores in PD rats.
  • The therapy effectively alleviated the level of ferroptosis, evidenced by decreased ROS and improved mitochondrial morphology.
  • Moxibustion treatment promoted the survival of dopaminergic neurons in the substantia nigra pars compacta (SNpc).

Conclusions:

  • Shi's moxa sticks demonstrate a significant capacity to suppress ferroptosis in the context of Parkinson's disease.
  • Moxibustion therapy improves dopaminergic neuron survival and motor function in PD rats, likely by mitigating ferroptosis.
  • These findings suggest moxibustion holds promise as a complementary and alternative therapy for Parkinson's disease patients.

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
606
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.0K
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.8K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.8K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.0K